{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:48:30Z","timestamp":1754153310963,"version":"3.41.2"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1136\/ijgc-2019-001069","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T02:34:35Z","timestamp":1590719675000},"page":"954-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2\u20133"],"prefix":"10.1016","volume":"30","author":[{"given":"Eduardo","family":"Gonzalez-Bosquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariona","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Hernandez-Saborit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Gonzalez-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-001069_bb0010","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1080\/21645515.2017.1289301","article-title":"HPV vaccines: global perspectives","volume":"13","author":"Gupta","year":"2017","journal-title":"Hum Vacc Immunotherapeut"},{"key":"10.1136\/ijgc-2019-001069_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","article-title":"The carcinogenicity of human papillomavirus types reflects viral evolution","volume":"337","author":"Schiffman","year":"2005","journal-title":"Virology"},{"key":"10.1136\/ijgc-2019-001069_bb0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines \u2013 a review of the first decade","volume":"146","author":"Harper","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001069_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/sextrans-2017-053109","article-title":"High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Cura\u00e7ao: implications for choice of prophylactic HPV vaccine","volume":"94","author":"Hooi","year":"2018","journal-title":"Sex Transm Infect"},{"key":"10.1136\/ijgc-2019-001069_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/viro.2001.0865","article-title":"Relationships between 80 human papillomavirus genotypes and different grades of cervical intraepithelial neoplasia: association and causality","volume":"283","author":"Matsukura","year":"2001","journal-title":"Virology"},{"key":"10.1136\/ijgc-2019-001069_bb0035","first-page":"101","article-title":"Gardasil-9: a global survey of projected efficacy","volume":"130","author":"Zhai","year":"2016","journal-title":"AntiviralRes"},{"key":"10.1136\/ijgc-2019-001069_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"B J Cancer"},{"key":"10.1136\/ijgc-2019-001069_bb0045","first-page":"779","article-title":"The 1988 Bethesda system for reporting cervical\/vaginal cytologic diagnoses. developed and approved at a national cancer Institute workshop, Bethesda, Maryland, USA, December 12\u201313, 1988","volume":"34","year":"1989","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2019-001069_bb0050","first-page":"269","article-title":"The role of colposcopy in modern gynecology","volume":"23","author":"Dexeus","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1136\/ijgc-2019-001069_bb0055","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ijgc-2019-001069_bb0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2019-001069_bb0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cncr.22688","article-title":"Significance and possible causes of false-negative results of reflex human papillomavirus infection testing","volume":"111","author":"Eltoum","year":"2007","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-001069_bb0070","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep"},{"year":"2015","author":"Saraiya","key":"10.1136\/ijgc-2019-001069_bb0075"},{"journal-title":"Human papilloma virus (HPV)-associated cancers. Atlanta, GA: US Department of Health and Human Services, CDC","year":"2015","author":"CDC","key":"10.1136\/ijgc-2019-001069_bb0080"},{"key":"10.1136\/ijgc-2019-001069_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-114","article-title":"Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand","volume":"13","author":"Simonella","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1136\/ijgc-2019-001069_bb0090","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.7314\/APJCP.2015.16.13.5153","article-title":"Human papillomavirus genotype distribution among Thai women with high-grade cervical intraepithelial lesions and invasive cervical cancer: a literature review","volume":"16","author":"Kietpeerakool","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1136\/ijgc-2019-001069_bb0095","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1136\/ijgc-2019-001069_bb0100","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S1470-2045(14)71179-9","article-title":"Next generation prophylactic human papillomavirus vaccines","volume":"16","author":"Schiller","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2019-001069_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pvr.2016.03.002","article-title":"Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region","volume":"2","author":"Castellsagu\u00e9","year":"2016","journal-title":"Papillomavirus Res"},{"key":"10.1136\/ijgc-2019-001069_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7137891","article-title":"Age-related changes in the fraction of cervical intraepithelial neoplasia grade 3 related to HPV genotypes included in the nonavalent vaccine","volume":"2019","author":"Giannella","year":"2019","journal-title":"J Oncol"},{"key":"10.1136\/ijgc-2019-001069_bb0115","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24001956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24001956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-001069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:37:58Z","timestamp":1753223878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24001956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1048891X24001956"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-001069","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2\u20133","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-001069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}